CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
Hye-Won LeeTerry Cheuk Fung YipVincent Wai-Sun WongYoung Suk LimHenry Lik Yuen ChanSang Hoon AhnGrace Lai-Hung WongJonggi ChoiPublished in: Alimentary pharmacology & therapeutics (2024)
/L) was significantly associated with HCC development after HBsAg seroclearance. CAMP-B score can be easily implemented in real-world clinical practice and helps stratify HCC risk in patients with CHB following HBsAg seroclearance.